Physician profile
Mark Dean
NPI 1144840224
$1,384.23
in general payments reported to CMS, 2019-2025
11 companies · $1,384 in 2025
The $1,384 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $281.74 | 2025 | Ultomiris |
| Biogen, INC. | $244.92 | 2025 | Vumerity, Tysabri, Leqembi |
| Argenx US, INC. | $206.28 | 2025 | Vyvgart Hytrulo |
| Eisai INC. | $179.11 | 2025 | |
| Amgen INC. | $145.76 | 2025 | Uplizna |
| Ucb, INC. | $124.98 | 2025 | Rystiggo |
| Ani Pharmaceuticals, INC. | $56.37 | 2025 | Purified Cortrophin Gel |
| Acadia Pharmaceuticals INC | $49.29 | 2025 | Nuplazid |
| Emd Serono, INC. | $40.89 | 2025 | |
| Tanabe Pharma America, INC. | $28.12 | 2025 | Radicava |
| Tg Therapeutics, INC. | $26.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.